October 29, 2015 | General
Two years ago I was introduced to Genentech’s innovation group to help them solve a clearly defined problem, that clinical trials are too slow, too painful, too expensive and not very patient-centric. The industries around this problem, especially telemedicine, had grown to the point that we were ready to implement a change. The idea was to use technology to bring the trial to the patient, to decentralize clinical trials. Read More